Sidney Lupkin
Appearances
NPR News Now
NPR News: 03-05-2025 6PM EST
Novo Nordisk is joining its competitor Eli Lilly and offering its obesity drug direct-to-consumers at a discount. Lilly started offering vials of its weight loss drug Zepbound online last summer. The direct-to-consumer model is fairly new to the pharmaceutical industry, but it wouldn't work for every medicine, says Dr. Ben Rome, a health policy researcher at Brigham and Women's Hospital in Boston.
NPR News Now
NPR News: 03-05-2025 6PM EST
According to the Centers for Disease Control and Prevention, two in five American adults is obese. Sydney Lepkin, NPR News.